Literature DB >> 21153093

Characterization of the second messengers involved in 1α,25-dihydroxyvitamin D(3) stimulated intestinal calcium absorption (transcaltachia).

L X Zhou1, A W Norman.   

Abstract

1α,25-Dihydroxyvitamin D(3) [1α,25(OH)(2)D(3)] has been shown to generate biological responses via both genomic and nongenomic pathways. In the nongenomic process, 1α,25(OH)(2)D(3) stimulates the rapid transport of Ca(2+) across the chick intestinal epithelial cell, a process termed transcaltachia. In previous studies, the involvement of Ca(2+)-channels, protein kinase C, and cAMP-dependent kinase in the 1α,25(OH)(2)D(3) stimulated transcaltachic response have been implicated. To further characterize the elements involved in mediating the transcaltachic effect, H7, an inhibitor of protein kinase C, U73122, an inhibitor of phospholipase C, and mastoparan, an activator of G-proteins, were employed. Both H7 and U73122 suppressed 1α,25(OH)(2)D(3) stimulated intestinal Ca(2+) transport. Mastoparan was found to mimic the effect of 1α,25(OH)(2)D(3) to stimulate transcaltachia. Collectively, these results suggest that 1α,25(OH)(2)D(3) activations of G-proteins, phospholipase C and protein kinases are essential steps in the rapid stimulation of intestinal Ca(2+) transport.

Entities:  

Year:  1996        PMID: 21153093     DOI: 10.1007/BF02738655

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

1.  1,25-Dihydroxycholecalciferol-dependent calcium uptake by mouse mammary gland in culture.

Authors:  G Mezzetti; M G Monti; L P Casolo; G Piccinini; M S Moruzzi
Journal:  Endocrinology       Date:  1988-02       Impact factor: 4.736

Review 2.  Receptor-coupled phospholipase D and its inhibition.

Authors:  N T Thompson; R W Bonser; L G Garland
Journal:  Trends Pharmacol Sci       Date:  1991-11       Impact factor: 14.819

3.  Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells.

Authors:  R Civitelli; Y S Kim; S L Gunsten; A Fujimori; M Huskey; L V Avioli; K A Hruska
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

4.  Rapid effects of 1,25-dihydroxyvitamin D3 and extracellular Ca2+ on phospholipid metabolism in dispersed porcine parathyroid cells.

Authors:  A Bourdeau; F Atmani; B Grosse; M Lieberherr
Journal:  Endocrinology       Date:  1990-12       Impact factor: 4.736

5.  Rapid nongenomic inhibition of renal 25-hydroxyvitamin D3 1-hydroxylase by 1,25-dihydroxyvitamin D3.

Authors:  I M Dick; R Retallack; R L Prince
Journal:  Am J Physiol       Date:  1990-08

Review 6.  1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry.

Authors:  P P Minghetti; A W Norman
Journal:  FASEB J       Date:  1988-12       Impact factor: 5.191

7.  Rapid accumulation of cyclic GMP near activated vitamin D receptors.

Authors:  J Barsony; S J Marx
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

8.  Effects of mastoparan and related peptides on phosphoinositide breakdown in HL-60 cells and cell-free preparations.

Authors:  F Gusovsky; D G Soergel; J W Daly
Journal:  Eur J Pharmacol       Date:  1991-04-25       Impact factor: 4.432

9.  Differential effects of 1,25-dihydroxyvitamin D3 on cytosolic calcium in two human cell lines (HL-60 and U-937).

Authors:  S S Desai; M C Appel; D T Baran
Journal:  J Bone Miner Res       Date:  1986-12       Impact factor: 6.741

10.  Rapid action of 1,25-dihydroxyvitamin D3 on hepatocyte phospholipids.

Authors:  D T Baran; A M Sorensen; T W Honeyman
Journal:  J Bone Miner Res       Date:  1988-12       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.